Zuellig Pharma Releases Ulipristal Acetate 5mg (UPA 5mg) Oral Treatment For Symptomatic Uterine Fibroids


pic2Almost 50% of women between the ages of 35 to 49 experience uterine fibroids, with 30% of them suffering from bothersome symptoms. Symptomatic uterine fibroids are the most common benign uterine tumor. Bothersome symptoms impede overall quality of life from sexual life, performance at work to relationships and family.

Symptoms include abnormal uterine bleeding, anemia, a feeling of pelvic pressure, urinary incontinence or retention or pain. Treatments for symptomatic uterine fibroids have traditionally been limited, with many women resorting to the surgery to manage the condition.

Zuellig Pharma has released Ulipristal Acetate 5mg (UPA 5mg), a first-in-class oral treatment for symptomatic uterine fibroids in Malaysia. UPA 5mg has been shown to rapidly control excessive menstrual bleeding within a week and progressively shrinks fibroids, with reductions in fibroid size maintained even after treatment.

UPA 5mg is a prescription-only medication and recommendations can be obtained from health care practitioners nationwide. The treatment consists of one tablet of UPA 5mg to be taken orally once daily for 3 months.[1]

[1] UPA 5mg Package Insert.